US Drug Recall Register

FDA Drug Recalls

1,122 recalls, newest first

Class II · Moderate risk Terminated

Ampicillin for Injection

Reason Lack of Assurance of Sterility

Astral SteriTech Private Ltd. NDC 70594-088-01 D-0589-2023
Class II · Moderate risk Terminated

Ampicillin for Injection

Reason Lack of Assurance of Sterility

Astral SteriTech Private Ltd. NDC 70594-087-02 D-0588-2023
Class II · Moderate risk Terminated

Ampicillin for Injection

Reason Lack of Assurance of Sterility

Astral SteriTech Private Ltd. NDC 70594-086-02 D-0587-2023
Class II · Moderate risk Terminated

Ampicillin for Injection

Reason Lack of Assurance of Sterility

Astral SteriTech Private Ltd. NDC 70594-085-02 D-0586-2023
Class II · Moderate risk Terminated

Ampicillin for Injection

Reason Lack of Assurance of Sterility

Astral SteriTech Private Ltd. NDC 70594-084-02 D-0585-2023
Class II · Moderate risk Terminated

Ampicillin for Injection

Reason Lack of Assurance of Sterility

Astral SteriTech Private Ltd. NDC 66794-224-15 D-0584-2023
Class II · Moderate risk Terminated

Ampicillin for Injection

Reason Lack of Assurance of Sterility

Astral SteriTech Private Ltd. NDC 66794-223-41 D-0583-2023
Class II · Moderate risk Terminated

Ampicillin for Injection

Reason Lack of Assurance of Sterility

Astral SteriTech Private Ltd. NDC 66794-222-41 D-0582-2023
Class II · Moderate risk Terminated

Ampicillin for Injection

Reason Lack of Assurance of Sterility

Astral SteriTech Private Ltd. NDC 66794-221-41 D-0581-2023
Class II · Moderate risk Terminated

Ampicillin for Injection

Reason Lack of Assurance of Sterility

Astral SteriTech Private Ltd. NDC 66794-220-41 D-0580-2023
Class II · Moderate risk Completed

Ascorbic Acid Preserved Injection Solution

Reason Mislabeling: preservative free product labeled as preserved.

Empower Clinic Services LLC dba Empower Pharmacy NDC 72627-2405-1 D-0865-2023
Class II · Moderate risk Terminated

Lorazepam Injection

Reason Failed Impurities/Degradation Specifications: Out-of-specification results for total related compounds observed during retain steting due to the elevated Related Compound-C.

Hikma Pharmaceuticals USA Inc. NDC 0641-6044-01 D-0574-2023
Class II · Moderate risk Ongoing

HYDROmorphone HCl 10 mg in 0.9% Sodium Chloridge

Reason CGMP Deviations: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.

SSM Health Care St. Louis DBA SSM St. Clare Health Center D-0776-2023